Table 4.
Spearman’s rank correlations for the dose-volume parameters versus peripheral blood cell counts
| Volume% (x ± S) | WBC nadirs | ANC nadirs | ALC nadirs | PLT nadirs | HGB nadirs | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | r | P | r | P | ||
| V5 | 99.52% | − 0.061 | .662 | − 0.096 | .491 | 0 | 1 | − 0.174 | .209 | − 0.09 | .516 |
| V10 | 98.05% | 0 | .999 | − 0.046 | .74 | − 0.105 | .448 | 0.162 | .243 | 0.155 | .263 |
| V15 | 90.86% | − 0.002 | .988 | 0.126 | .364 | − 0.051 | .717 | − 0.085 | .541 | − 0.036 | .798 |
| V20 | 74.08% | − 0.063 | .651 | 0.103 | .457 | − 0.122 | .378 | − 0.258 | .06 | − 0.114 | .41 |
| V30 | 39.67% | − 0.197 | .154 | − 0.011 | .939 | − 0.209 | .129 | − 0.246 | .073 | − 0.264 | .054 |
| V40 | 16.32% | − 0.364 | .007* | − 0.203 | .145 | − 0.186 | .181 | 0 | .999 | − 0.357 | .009* |
| V50 | 5.93% | − 0.05 | .756 | 0.061 | .703 | 0.08 | .615 | 0.035 | .824 | − 0.226 | .151 |
*Statistically significant